A method for treating and/or preventing VacA+ H. pylori infection and a disorder associated with VacA+ H. pylori infection is provided. The method comprises the administration of TRPML agonists such as ML-SA1, SF-22, SF-51, MK6-83 and their derivatives.
提供了一种治疗和/或预防VacA+幽门螺杆菌感染和与VacA+幽门螺杆菌感染相关的疾病的方法。该方法包括服用 TRPML 激动剂,如 ML-
SA1、SF-22、SF-51、MK6-83 及其衍
生物。